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Summary A high suicide mortality risk has been documented among a population-based cohort of 27 123 cancer patients resident in central
Italy where the general suicide rate is low. Forty-one suicides were observed (SMR = 2.36) which were only 0.2% of all deaths. However, the
highest risk (SMR = 27.7) during the first 6 months after diagnosis, represents a greater contrast with the general population than has been
observed in other studies.
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An increased suicide risk has been shown for cancer patients in
some population-based studies (Campbell, 1966; Louhivuori and
Hakama, 1979; Olafsen, 1981; Fox et al, 1982; Allebeck et al,
1989; Chatton-Reith et al, 1990; Allebeck and Bolund, 1991; Levi
et al, 1991; Storm et al, 1992; Louhivuori, 1993; Tanaka et al,
1996). All these studies have been carried out in countries with
suicide rates in the general population that are from two to five
times greater than in Italy (La Vecchia et al, 1994).
Some of these studies evidenced a high risk near the time of
cancer diagnosis (Fox et al, 1982; Allebeck and Bolund, 1991;
Chatton-Reith et al, 1990; Levi et al, 1991; Storm et al, 1992;
Tanaka et al, 1996). During the first year after diagnosis the risk
varied from two to five times the expected (Allebeck et al, 1989;
Allebeck and Bolund, 1991; Levi et al, 1991; Storm et al, 1992;
Tanaka et al, 1996), but among Swedish cancer patients it was
considerably higher (SMR = 16.0 for men and SMR = 15.4 for
women) (Allebeck et al, 1989).
The purpose of the present study was to estimate the risk of
suicide among cancer patients resident in a low-risk area for
suicide mortality, and its relationship with time since diagnosis.
MATERIALS AND METHODS
In the provinces of Florence and Prato, central Italy (about
1 200 000 inhabitants), a population-based cancer registry, the
Tuscany Cancer Registry (RTT), has been active since 1984
(Buiatti et al, 1992).
After the exclusion of non-melanomatous skin cancers (2361
cases, 7.6%), cancers known from the death certificate only
(DCO = 1355 cases, 4.4%) or from autopsy only (69 cases, 0.2%),
27 123 incident cancer cases (14 683 men and 12 440 women)
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registered between 1985 and 1989 were analysed. Each patient has
been actively followed up from the date of diagnosis until the
earliest of the following dates: date of death, date of withdrawal
from the study because of loss of contact (208 subjects, 0.8%) or
31 December 1994.
The mortality codes for suicide (E950-E959) and those for
undetermined violent causes (whether accidentally or purposely
inflicted) (E980-E989) were considered. The latter category was
included because a substantial proportion ofthese deaths is gener-
ally considered to be due to suicide (Allebeck et al, 1991).
The expected number of suicide deaths was estimated by
multiplying age- and sex-specific suicide mortality rates from the
Tuscan region from 1987 to 1994 by the corresponding person-
years of observation. The standardized mortality ratio (SMR) for
suicide was calculated as the observed to expected ratio. The P-
value was calculated assuming a Poisson distribution for the
observed number of suicides.
RESULTS
By the end of 1994, 18 566 out of 27 123 cancer patients had died
(68.5%) and among those 41 (0.2%) were registered as suicides.
In Table 1, the main results are shown. The cohort was observed
for 89 158.4 person-years and 17.37 deaths due to suicide were
expected, SMR = 2.36 (95% CI 1.69-3.20). There were 31
suicides among men (SMR = 2.26, 95% CI 1.54-3.21) and ten
among women (SMR = 2.74, 95% CI 1.31-5.04).
The suicide risk was significantly elevated in all age groups
relative to the general population, except for persons younger than
54 years ofage.
According to time since cancer diagnosis, the highest risk was
observed during the first 6 months (SMR = 27.7, 95% CI 13.8-
49.6). This finding was confirmed in both genders (men: SMR =
22.9, 95% CI 9.9-45.2; women: SMR = 62.6, 95% CI 9.4-133.6).
During the second period, the risk was still significantly increased
in men (SMR = 11.36, 95% CI 3.7-26.5) but not in women
(SMR = 15.23, 95% CI 0.37-79.6). Overall, the SMR for the first
year was 18.8 (95% Cl 1.0-30.1).
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Table 1 Observed number of suicides among cancer patients and
standardized mortality ratio (SMR = observed suicides/expected ones,
according to general population rates) by gender, age and latency from
diagnosis. Tuscany Cancer Registry, 1985-89
Observed SMR P-value
Global 41 2.36 <0.001
Gender
Male 31 2.26 <0.001
Female 10 2.74 <0.05
Age (years)
0-54 0 - NS
55-64 10 3.94 < 0.001
65-74 16 2.98 < 0.001
75+ 15 1.85 < 0.05
Time since diagnosis
< 6 months 11 27.7 < 0.001
7-12 months 6 11.8 < 0.001
First year 17 18.8 < 0.001
Second year 5 4.72 < 0.01
Third year 5 5.09 <0.01
Fourth year 5 5.43 < 0.05
> Fifth year 9 0.67 NS
Although SMRs decreased notably over time, the excess risk
was significant up to the fourth year after diagnosis.
DISCUSSION
The results of this study, carried out in a low suicide mortality
area, indicate a greater risk for suicide among cancer patients. The
risk was elevated in both genders and across subsequent age
groups. These results are consistent with the main results of other
population-based studies carried out in Connecticut (Campbell,
1996; Fox et al, 1982), Scandinavia (Louhivuori and Hakama,
1979; Olafsen, 1981; Storm et al, 1992; Louhivuori, 1993),
Switzerland (Chatton-Reith, 1990; Levi et al, 1991) and Japan
(Tanaka et al, 1996).
Among 18 566 patients who had died, only 41 deaths were
registered as suicide; therefore, in absolute terms, suicide appeared
as a minor cause of death for cancer patients. It is possible,
however, that the under-reporting of suicide has been greater for
cancer patients than for the general population. For example,
among the means used by cancer patients for committing suicide,
there was a lower percentage of poisoning than that among
suicides occurring in the general population ofthe area from 1987
to 1995 (11.3% vs 2.4%) (Crocetti et al, unpublished data). Also,
in Sweden (Allebeck et al, 1989), poisoning, which ranks first
among methods both for cancer patients and for the general popu-
lation, was less represented in the former group. Cancer patients
have easier access to drugs, such as analgesics or tranquillizers,
than the general population. Possibly, physicians may be reluctant
to classify an overdose of drugs as suicide in a cancer patient
(Chatton-Reith et al, 1990).
The risk was highest near the time of cancer diagnosis, as in
some other studies (Fox et al, 1982; Allebeck et al, 1989; Storm et
al, 1992; Tanaka et al, 1996). During the first year after cancer
diagnosis, a relative risk of 18.8 was shown, exceeding results in
the Swedish study (Allebeck et al, 1989), which had been the
highest previously reported. Thus, the present study suggests that,
in Italy, risk of suicide after a cancer diagnosis may be, in
comparison with the general population, greater than previously
estimated. As suggested by Allebeck and Fox (Fox et al, 1982;
Allebeck et al, 1989), these results could be related to the so-called
'Law ofthe Initial Values', according to which the effect ofcancer
on suicide mortality would be higher if the initial suicide rates in
the general population were lower. In fact, in the area of the
Tuscany Cancer Registry, suicide rates in the general population
are notably lower than in the areas where similar studies have been
carried out. We included, as in the Swedish study (Allebeck et al,
1989), the group of undetermined causes (whether accidentally or
purposely inflicted) among suicide deaths (2 out of 41 deaths).
This could have overestimated the suicide risk. However, none of
the undetermined deaths occuffed during the first year after cancer
diagnosis.
The highest risk has been evidenced during the first 6 months
after diagnosis. During this period, a patient has to cope with two
factors that both potentially increase the risk ofsuicide: the aware-
ness of diagnosis and the disease-related symptoms. We have no
information about these patients' awareness of their cancer diag-
nosis. However, cancer in Italian culture is strongly associated
with pain, suffering and death, and frequently the relatives, in
agreement with physicians, keep the truth from the patient
(Veronesi et al, 1995). With regard to the seriousness of the
disease, during the first year after diagnosis, 10 778 out of 27 123
patients (39.7%) died, the majority of them because of a particu-
larly aggressive cancer or of a diagnosis occurring in advanced
phases. The effects of the aggressiveness of the disease, such as
pain, loss ofautonomy, depression and consciousness oftreatment
failures could lead to the loss of hope and to suicide (Whitlock,
1978).
In conclusion, although suicide was rather unusual, cancer
patients had an increased risk more than twice that of the general
population. More than a quarter ofsuicides were committed within
the first 6 months from cancer diagnosis, and during the first year
after diagnosis the SMR was greater than has previously been
estimated in other studies.
These findings need to be considered when evaluating the
psychological and social needs of cancer patients, especially
during the period near to diagnosis.
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